Ipamorelin

What it's for

Ipamorelin is a lab-made peptide studied for nudging the body to release growth hormone.

What it does for the body

It has been researched for growth hormone-release patterns. It is not FDA-approved to treat aging, fat loss, or muscle building. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.

What it targets

It acts on ghrelin-related receptors (landing spots on cells) that help trigger growth hormone release from the pituitary. Imagine a thermostat nudge for growth hormone — not pouring hormone in directly. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.

Research context

Often discussed alongside other growth-hormone release-nudge (secretagogue) peptides in research contexts. Educational only — not instructions for use.

Studied for (literature interest)

• Growth-hormone release-nudge signal research
• Interest in recovery and body-composition literature — limited definitive clinical use evidence

Cautions (educational)

• Not FDA-approved for general human use as a wellness peptide.
• This encyclopedia does not provide dosing or sourcing.

Citations / starters

• PubMed search: Ipamorelin — NCBI PubMed
• ClinicalTrials.gov search: Ipamorelin — U.S. clinical trials registry
• FDA search: Ipamorelin — FDA.gov
• Drugs@FDA search: Ipamorelin — FDA drug database (if approved)
• OpenAlex works: Ipamorelin — Open scholarly index

Reference

Ref $55 ref only